Physician Scientist, University of Colorado | MDS, AML |
Maria Amaya MD PhD
Loading...
The work of a talented trainee with biorender! Happy holidays from the Amaya and Marchetti’s labs! Couldn’t ask for a more amazing group of people to work with 💕
It’s been a tough year so sun, palm trees is what we needed to end the year! 🌴🌴🌴🌴☀️☀️🕶️
We had so much fun at the myeloid meeting and congrats to Keishla on her poster! Until next time!
Coming up later this month is AML World Awareness Day! So tomorrow morning at 8:30am, we will be talking about AML in the radio show “Hablemos Hoy” (Emisora La Buena Honda 1150AM) in Spanish!
Our lab, the Lego version!
The ASCEND program aims to coordinate and accelerate cell and gene therapy clinical trials—an area rich with promise, but complex in execution. Learn more about this new chapter in the CU Anschutz’s commitment to patients with serious and rare diseases: https://bit.ly/4cr0jPT
Great day at the department of medicine research day! So proud of the team and especially proud Keishla for winning an abstract award! @cudeptofmedicine.bsky.social
That’s a wrap for me for #ASH25! So many great things! Oral therapies for myeloid malignancies, aza/ven for the win for AML, CDK inhibitors to avoid t-MN? And can we finally give IV iron to pts with infections? Also, ASH daycare always saves the day!
Had an amazing time at ALF 2026, many great and inspirational talks!
Maria Amaya MD PhD
Maria Amaya MD PhD
Maria Amaya MD PhD
Maria Amaya MD PhD
Maria Amaya MD PhD
Maria Amaya MD PhD
Maria Amaya MD PhD
Maria Amaya MD PhD
CU Anschutz School of Medicine
The Accelerating Solutions for Cell and Gene Therapy Evaluation and Novel Delivery (ASCEND) was created to coordinate and accelerate cell and gene therapy clinical trials at CU Anschutz. Gates Institu...
